<?xml version="1.0" encoding="UTF-8" standalone="yes"?><ns0:RetrieveMultipleValueSetsResponse xmlns:ns0="urn:ihe:iti:svs:2008" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">    <ns0:DescribedValueSet ID="2.16.840.1.113883.3.666.5.736" displayName="Fibrinolytic Therapy" version="N/A">        <ns0:ConceptList>            <ns0:Concept code="1804799" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="alteplase 100 MG Injection"/>            <ns0:Concept code="1804804" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="alteplase 50 MG Injection"/>            <ns0:Concept code="313212" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="Tenecteplase 50 MG Injection"/>            <ns0:Concept code="763138" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="Reteplase 10 UNT Injection"/>        </ns0:ConceptList>        <ns0:Source>Lantana</ns0:Source>        <ns0:Purpose>(Clinical Focus: This value set contains concepts that represent medications that are prescribed for fibrinolytic therapy in patients with an episode of acute myocardial infarction.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Administered. The intent of this data element is to identify patients who are prescribed fibrinolytic therapy during an episode of an acute myocardial infarction.),(Inclusion Criteria: Includes only relevant concepts associated with generic and prescribable fibrinolytic agents. Only injectable dose forms should be included. Single ingredient.),(Exclusion Criteria: No exclusions.)</ns0:Purpose>        <ns0:Type>Extensional</ns0:Type>        <ns0:Binding>Dynamic</ns0:Binding>        <ns0:Status>Active</ns0:Status>        <ns0:RevisionDate>2017-05-04</ns0:RevisionDate>    </ns0:DescribedValueSet></ns0:RetrieveMultipleValueSetsResponse>